Freedom Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Freedom Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,437	Closed	-$173K	–	1212
2017 Q3	$173K	Sell	15,437 -30,810	-67%	-$340K	0.01%	1036
2017 Q2	$509K	Buy	46,247 +32,943	+248%	+$330K	0.03%	555
2017 Q1	$130K	Sell	13,304 -20,418	-61%	-$204K	0.01%	1013
2016 Q4	$364K	Buy	+33,722	New	+$337K	0.02%	609
2016 Q3	–	Sell	-25,359	Closed	-$331K	–	972
2016 Q2	$331K	Buy	+25,359	New	+$332K	0.02%	554

Freedom Investment Management's SCLN Position: Q4 2017 in Review

Freedom Investment Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 15,437 shares — an estimated $173K sold.

Freedom Investment Management first reported a position in SCLN in Q2 2016 and held it in 5 quarters. The position peaked at $509K in Q2 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

Freedom Investment Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Freedom Investment Management sold 15,437 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $173K.
Freedom Investment Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2016 and held it in 5 quarters.
Freedom Investment Management's Sciclone Pharmaceuticals Inc position peaked at $509K in Q2 2017.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Freedom Investment Management's 13F filing for Q4 2017, filed 25 Jan 2018.